Linda M. Catanzaro, Pharm.D.

Clinical Assistant Professor
Department of Pharmacy Practice
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
HIV Pharmaceutical Care Specialist
Adherence-Pharmacology Unit Coordinator
Erie County Medical Center
Email: lburow@buffalo.edu

• DHHS, Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. February 4, 2002 (aidsinfo.nih.gov).
• MEDSCAPE Quick Reference Guide to Antiretrovirals (Medscape.com)

• DHHS, Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. February 4, 2002 (aidsinfo.nih.gov)

• Gallant JE. Treatment Strategies for the Antiretroviral-Experienced Patient MEDSCAPE HIV/AIDS Update 2002. (Medscape.com)

• Esch LD. Issues in Human Immunodeficiency Virus (HIV) Pharmacotherapy Practice: The Emerging Role of Pharmacotherapy Specialists in Enhancing Antiretroviral Success. J Inform Pharmacother 2001;4:306-316 (http://hiv.buffalo.edu).
• Esch LD,Shelton MJ, Hewitt RG, Morse GD. Pharmacologic and adherence factors complicating antiretroviral therapy for HIV. Recent Research Developments in Antimicrobial Agents & Chemotherapy; Volume 3(1999) Part II, Page 483-496 (http://hiv.buffalo.edu).
• Stone V. Enhancing Adherence to Antiretrovirals: Strategies and Regimens. MEDSCAPE HIV/AIDS Update 2002. (Medscape.com)

• Dube, MP; Sprecher, D; Henry, WK, et. al. Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Clin. Infect. Dis. 2000; 31:1216-1224.
• Mallal SA. Mitochondrial Toxicity. MEDSCAPE HIV/AIDS Update 2002. (Medscape.com)
• Moyle G and Baldwin C. Management of Morphologic Changes During Antiretroviral Therapy: Insights from Etiology. MEDSCAPE HIV/AIDS Update 2002. (Medscape.com)

• Acosta E., Gerber J., and the Adult Pharmacology Committee of the AIDS Clinical Trials Group. Position Paper on Therapeutic Drug Monitoring of Antiretroviral Agents. AIDS Research and Human Retroviruses 2002;18(12):825-34.

• USPHS/IDSA. 2001 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus. November 28, 2001. (aidsinfo.nih.gov)

• Guidelines for the Use of Antiretrovirals in Pregnancy (aidsinfo.nih.gov)

• Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (NPHRC). (aidsinfo.nih.gov)